TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7609496

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 0
Study: 2907519

Group type: EXPERIMENTAL
Intervention: Propranolol (40, 80 mg twice daily)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Ketanserin (20, 40 mg twice daily)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination treatment (Propranolol added to Ketanserin)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination treatment (Ketanserin added to Propranolol)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 33
Study: 31854481

Group type: EXPERIMENTAL
Intervention: Intervention: Parents were responsible for booking consultations and contacting the clinic as needed.
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control: Year prior to intervention where parents were not responsible for booking consultations.
Number of subjects: 139
Study: 31745107

Group type: EXPERIMENTAL
Intervention: IV DMT
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 28994705

Group type: EXPERIMENTAL
Intervention: Purified anthocyanins (320 mg/day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 25450868

Group type: EXPERIMENTAL
Intervention: Injection of sclerosant through an occluding balloon catheter (OB technique)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Injection of sclerosant through a diagnostic catheter (free catheter technique)
Number of subjects: 90
Study: 23553796

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy with immediate surgery (SRT)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Short-course radiotherapy with surgery delayed for 4-8 weeks (SRT-delay)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Long-course radiotherapy with surgery delayed for 4-8 weeks (LRT-delay)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (low ratio)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (intermediate ratio)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Postoperative to preoperative leucocyte ratio (high ratio)
Number of subjects: 657
Study: 21692281

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with psychological interference (combined therapy group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined therapy group (EA + psychotherapy)
Number of subjects: 120
Study: 19453574

Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius WB21 (2.01 x 10(9) CFU/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo with xylitol
Number of subjects: 66
Study: 16310718

Group type: EXPERIMENTAL
Intervention: Extensive multidisciplinary treatment program
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Light multidisciplinary treatment program
Number of subjects: 208

Group type: COMPARATOR
Intervention: Treatment-as-usual initiated by a general practitioner
Number of subjects: 208
Study: 15110919

Group type: EXPERIMENTAL
Intervention: Newborns with parental atopy and elevated cord IgE (> or = 0.5 kU/l)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Newborns without parental atopy and normal cord IgE
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: All newborns
Number of subjects: 51
Study: 11142547

Group type: EXPERIMENTAL
Intervention: EMDR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-placebo control
Number of subjects: 0
Study: 9311710

Group type: EXPERIMENTAL
Intervention: Neoral (10 mg/kg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sandimmune (10 mg/kg/day)
Number of subjects: 33
Study: 8141713

Group type: COMPARATOR
Intervention: Streptokinase (SK) and subcutaneous heparin (n = 9796)
Number of subjects: 40845

Group type: COMPARATOR
Intervention: Streptokinase (SK) and intravenous heparin (n = 10,377)
Number of subjects: 40845

Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (t‐PA) and intravenous heparin (n = 10,344)
Number of subjects: 40845

Group type: EXPERIMENTAL
Intervention: Combined SK and t‐PA (n = 10,328)
Number of subjects: 40845
Study: 3490744

Group type: EXPERIMENTAL
Intervention: Plain chest radiographs showing widening of the mediastinum
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Plain chest radiographs showing widening of the aortic knob
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall accuracy of radiologists' predictions
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Interobserver agreement on radiographic features
Number of subjects: 72
Study: 30021545

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention provided by rehabilitation coordinators at primary health care centers.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual provided by rehabilitation coordinators at primary health care centers.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0
Study: 27084867

Group type: EXPERIMENTAL
Intervention: Aloe vera gel along with physiotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antioxidant capsules along with physiotherapy
Number of subjects: 40
Study: 24819103

Group type: EXPERIMENTAL
Intervention: Porcine-derived acellular dermal matrix reinforcement
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard end-stoma construction without reinforcement
Number of subjects: 113
Study: 22922507

Group type: EXPERIMENTAL
Intervention: Baseline heart rate 77-82 b.p.m.
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Baseline heart rate >82 b.p.m.
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Baseline heart rate 71-76 b.p.m.
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Lower heart rate across all groups
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Baseline heart rate associated with cognitive decline
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Low heart rate
Number of subjects: 20165

Group type: EXPERIMENTAL
Intervention: Baseline heart rate
Number of subjects: 20165
Study: 20020319

Group type: EXPERIMENTAL
Intervention: Autism 1-2-3 early intervention for 2 weeks targeting eye contact, gesture, and vocalization/words
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 17
Study: 18678836

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus docetaxel (AT)
Number of subjects: 2882

Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide (AC)
Number of subjects: 2882
Study: 15946410

Group type: EXPERIMENTAL
Intervention: GLU+FRUC (1.2 g/min glucose + 1.2 g/min fructose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: GLU (1.2 g/min glucose)
Number of subjects: 8
Study: 12680333

Group type: EXPERIMENTAL
Intervention: Intrameatal application of low dosage alprostadil (PGE1) cream (300 mcg)
Number of subjects: 43
Study: 10525926

Group type: EXPERIMENTAL
Intervention: Metoprolol (1mg/kg/BW) starting on day one after operation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (therapy only in case of occurrence of atrial fibrillation)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Metoprolol group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 8693245

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery and/or radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 1846940

Group type: EXPERIMENTAL
Intervention: Interferon gamma (50 micrograms per square meter of body-surface area)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Interferon gamma
Number of subjects: 128
Study: 6402129

Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Carotid surgery
Number of subjects: 959
Study: 31040096

Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated PICC (miconazole and rifampicin)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Standard PICC (non-antimicrobial-impregnated)
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated PICC
Number of subjects: 861

Group type: COMPARATOR
Intervention: Standard PICC
Number of subjects: 861
Study: 30084415

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) and Daclatasvir (DAC) for 24 weeks
Number of subjects: 61
Study: 26800444

Group type: EXPERIMENTAL
Intervention: Single-session group lyric analysis intervention
Number of subjects: 144

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 144
Study: 24191261

Group type: EXPERIMENTAL
Intervention: CBCT1 system with metallic posts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Digital radiographs with metallic posts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CBCT2 system with metallic posts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Film radiographs without metallic posts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Digital radiographs without metallic posts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CBCT1 examination
Number of subjects: 100
Study: 22128083

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg
Number of subjects: 356

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 356
Study: 20626055

Group type: EXPERIMENTAL
Intervention: External Qigong Treatment (EQT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Equivalent Attention Time (EAT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EQT
Number of subjects: 50
Study: 17405567

Group type: EXPERIMENTAL
Intervention: New drug-elution stents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established methods in interventional cardiology
Number of subjects: 0
Study: 15805203

Group type: EXPERIMENTAL
Intervention: 135 degrees four‐hole sliding hip screw (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: External fixation device with hydroxyapatite‐coated pins (Group B)
Number of subjects: 40
Study: 12578811

Group type: EXPERIMENTAL
Intervention: Indomethacin (3 microg/min)
Number of subjects: 25
Study: 10381908

Group type: EXPERIMENTAL
Intervention: rNV VLPs (250 micrograms) administered orally on days 1 and 21
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: rNV VLPs (250 micrograms) administered orally
Number of subjects: 20
Study: 8917873

Group type: EXPERIMENTAL
Intervention: DSS (Computerized Decision Support)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Hospital dosing
Number of subjects: 49
Study: 1748137

Group type: EXPERIMENTAL
Intervention: Hypocapnic alkalosis (HA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 12
Study: 6123675

Group type: EXPERIMENTAL
Intervention: Metkephamid acetate 70 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pethidine hydrochloride 100 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 28872396

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) group, exercises on the vibrating platform turned on, at a frequency of 50 Hz and amplitude of 4 mm
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group, exercise protocol on the vibrating platform turned off
Number of subjects: 44
Study: 28694884

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Local steroid injections
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined therapy (exercise + local steroid injections)
Number of subjects: 30
Study: 25565079

Group type: EXPERIMENTAL
Intervention: Box-Cox transformation method for treatment effect estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Box-Cox transformation method
Number of subjects: 0
Study: 23321257

Group type: EXPERIMENTAL
Intervention: Reinforced induction course
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard induction course
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Achieved 3-log MRD reduction
Number of subjects: 198
Study: 20872043

Group type: EXPERIMENTAL
Intervention: Sunitinib malate at a daily dose of 37.5 mg until progression or unacceptable toxicity
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sunitinib malate at a daily dose of 37.5 mg
Number of subjects: 21
Study: 18534911

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation in addition to specialist nurse outpatient clinic
Number of subjects: 0
Study: 16697808

Group type: EXPERIMENTAL
Intervention: Novel catheter technique (no urethral catheter, handmade cystostomy catheter)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Traditional procedure (cystostomy and urethral catheter)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Novel catheter technique
Number of subjects: 146

Group type: COMPARATOR
Intervention: Traditional procedure
Number of subjects: 146
Study: 15514186

Group type: EXPERIMENTAL
Intervention: Outreach care (3 telephone calls and 1 home visit within 5 months)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Outreach care
Number of subjects: 536
Study: 10945486

Group type: EXPERIMENTAL
Intervention: Irinotecan single-agent after 5-FU failure
Number of subjects: 455
Study: 9294406

Group type: EXPERIMENTAL
Intervention: Dysport (muscle-relaxant doses)
Number of subjects: 295

Group type: COMPARATOR
Intervention: BOTOX
Number of subjects: 295

Group type: COMPARATOR
Intervention: Dysport
Number of subjects: 295

Group type: COMPARATOR
Intervention: Both BOTOX and Dysport
Number of subjects: 295

Group type: COMPARATOR
Intervention: Untreated volunteers
Number of subjects: 295

Group type: COMPARATOR
Intervention: Immunized subjects
Number of subjects: 295
Study: 8335048

Group type: EXPERIMENTAL
Intervention: DEX + OND
Number of subjects: 36

Group type: COMPARATOR
Intervention: DEX + ALI
Number of subjects: 36
Study: 3595569

Group type: EXPERIMENTAL
Intervention: Pretreatment with propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone, suxamethonium, intubation induction sequence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone, alcuronium, intubation induction sequence
Number of subjects: 0
Study: 30899941

Group type: EXPERIMENTAL
Intervention: Twin-block appliance treatment in experimental group (21 patients)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (12 patients)
Number of subjects: 33
Study: 27434280

Group type: EXPERIMENTAL
Intervention: Proprioceptive exercises
Number of subjects: 45

Group type: COMPARATOR
Intervention: Isometric quadriceps exercise
Number of subjects: 45
Study: 24275841

Group type: EXPERIMENTAL
Intervention: Candesartan (ARB) for 2 years
Number of subjects: 772

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 772

Group type: COMPARATOR
Intervention: Candesartan and Placebo
Number of subjects: 772
Study: 22508710

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation at 4000 IU/d for 1 year
Number of subjects: 52
Study: 21182783

Group type: EXPERIMENTAL
Intervention: Levosimendan 0.2 μg·kg(‐1)·min(‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dobutamine 5 μg·kg(‐1)·min(‐1) (control)
Number of subjects: 40
Study: 19102151

Group type: EXPERIMENTAL
Intervention: Self-made spinal expander and bone cement
Number of subjects: 96

Group type: COMPARATOR
Intervention: PVP
Number of subjects: 96
Study: 16621906

Group type: EXPERIMENTAL
Intervention: Gonadotropin suppression by GnRH antagonist (cetrorelix) with testosterone and additional administration of the gestogen desogestrel (CTD group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gonadotropin suppression by GnRH antagonist (cetrorelix) with testosterone (CT group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 30
Study: 14708413

Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Oral calcitriol
Number of subjects: 34
Study: 11236258

Group type: EXPERIMENTAL
Intervention: Patients with ulcerative colitis
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patients with ulcerative colitis with rectum-limited inflammatory process
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy persons
Number of subjects: 42
Study: 8640161

Group type: EXPERIMENTAL
Intervention: Chemotherapy and colony-stimulating factors (group I)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: G‐CSF alone (18 patients)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (patients who did not mobilize CD34+ cells)
Number of subjects: 24
Study: 1464047

Group type: EXPERIMENTAL
Intervention: Nasal beclomethasone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3883265

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29572630

Group type: COMPARATOR
Intervention: Water (group D)
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Pronase (group A)
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Simethicone (group B)
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Pronase and Simethicone (group C)
Number of subjects: 7200

Group type: COMPARATOR
Intervention: Control group (water) vs. Premedication groups (A, B, C)
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for esophageal lesions
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for overall lesions
Number of subjects: 7200
Study: 27288354

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (O/O)
Number of subjects: 1236

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1236

Group type: COMPARATOR
Intervention: placebo/onabotulinumtoxinA (P/O)
Number of subjects: 1236
Study: 26715196

Group type: EXPERIMENTAL
Intervention: Liberal transfusion (30 ml/kg whole blood)
Number of subjects: 3954

Group type: EXPERIMENTAL
Intervention: Conservative transfusion (20 ml/kg)
Number of subjects: 3954

Group type: COMPARATOR
Intervention: No transfusion (control)
Number of subjects: 3954

Group type: EXPERIMENTAL
Intervention: Post-discharge multi-vitamin multi-mineral supplementation (including folate and iron)
Number of subjects: 3954

Group type: COMPARATOR
Intervention: Routine care (folate and iron)
Number of subjects: 3954

Group type: EXPERIMENTAL
Intervention: Post-discharge cotrimoxazole prophylaxis
Number of subjects: 3954

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 3954
Study: 24384959

Group type: EXPERIMENTAL
Intervention: ATP‐TCA directed chemotherapy regimen (specific regimens include paclitaxel+carboplatin, paclitaxel+oxaliplatin, bleomycin+ifosfamide+cisplatin, bleomycin+vincristine+cisplatin, fluorouracil+cisplatin, gemcitabine+cisplatin)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group chemotherapy regimen confirmed by clinical experience
Number of subjects: 72
Study: 20473991

Group type: EXPERIMENTAL
Intervention: Soybean plus fish oil emulsion (1.0 and 0.2 g per kg per day respectively)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Soybean oil alone (1.2 g per kg bodyweight per day; control group)
Number of subjects: 206
Study: 19052244

Group type: EXPERIMENTAL
Intervention: Strengthening of quadriceps plus strengthening of hip abductor and lateral rotator muscles
Number of subjects: 14

Group type: COMPARATOR
Intervention: Strengthening of quadriceps
Number of subjects: 14
Study: 15843115

Group type: EXPERIMENTAL
Intervention: Individually tailored, multidimensional intervention (15 structured sessions of 90 minutes each)
Number of subjects: 943
Study: 12610030

Group type: EXPERIMENTAL
Intervention: Pathways To Change (PTC) plus free blood testing strips
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Pathways To Change (PTC)
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) plus free blood testing strips
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Pathways To Change (PTC) for healthy eating
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Pathways To Change (PTC) for healthy eating with increased SMBG frequency
Number of subjects: 1029
Study: 10485555

Group type: EXPERIMENTAL
Intervention: PPV with fluid‐gas exchange and endolaser
Number of subjects: 283
Study: 8984878

Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope in neutral position
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope in best position
Number of subjects: 177

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope in patients where vocal cords could not be seen with Macintosh
Number of subjects: 177
Study: 1817898

Group type: EXPERIMENTAL
Intervention: Prilocaine 3% with Felypressin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Articaine 4% with Epinephrine 1/200,000
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with Epinephrine 1/100,000
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Articaine 4% with Epinephrine 1/100,000
Number of subjects: 0
Study: 7040158

Group type: EXPERIMENTAL
Intervention: Bethanechol and antacid
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo and antacid
Number of subjects: 28
Study: 31263555

Group type: EXPERIMENTAL
Intervention: mHealth application (smartphone equipped)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Paper-based control
Number of subjects: 520
Study: 28274246

Group type: EXPERIMENTAL
Intervention: PBMCs stimulated for cytokine production after day 3
Number of subjects: 95

Group type: COMPARATOR
Intervention: TNF‐α production less than 250 pg/ml after lipopolysaccharide stimulation on day 3
Number of subjects: 95

Group type: COMPARATOR
Intervention: Cardiovascular failure on admission
Number of subjects: 95
Study: 27208415

Group type: EXPERIMENTAL
Intervention: Trehalose (100 g/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Maltose (isocaloric control)
Number of subjects: 32
Study: 24954518

Group type: EXPERIMENTAL
Intervention: Time-lapse monitoring (Group A)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional incubator (Group B)
Number of subjects: 138